To examine the impacts of three functional variants on the risk of developing APOE4-associated cognitive decline (MCI or dementia), we assessed the APOE4-associated risk by stratification based on the genotype of each of the three variants (S4 Table), although power calculations showed limited statistical power (ranging from 32% to 55%) in each stratum. The gene discussed is APOE; the disease is Mental deterioration.